$Ogrmf Responds To Proposed Class Action Suit

Organigram Responds to Proposed Class-Action Suit

Licensed marijuana producer Organigram Inc. and its parent company Organigram Holdings Inc. (TSX VENTURE:OGI)(OGRMF) (collectively, the “Company” or “Organigram“) will launch a strong defense against a proposed class-action suit related to recent voluntary product recalls.

The Company was served with notice of the proceeding yesterday. The proposed suit was filed with the Supreme Court of Nova Scotia by a Halifax-based law firm. The filing seeks to represent Organigram clients who purchased and consumed medical marijuana that was later found to contain trace elements of the pesticides myclobutanil and bifenazate which are not approved for use by licensed growers. Denis Arsenault, Organigram’s Chief Executive Officer, said the Company offered all non-insured clients impacted by the voluntary recall an account credit equal to the full purchase price of the recalled product. He also noted that public comments made yesterday by the...



See Article on Marijuana Stocks HERE